SWK Holdings Corp. (NASDAQ: SWKH), a specialty finance company focused on the life sciences sector, announced on October 1, 2025, that Elutia, Inc. has fully repaid its loan with a $27.8 million payoff. This payment, which includes outstanding principal, exit fees, and accrued interest, follows Elutia's $88 million sale of its BioEnvelope business to Boston Scientific Corporation. The repayment exceeds SWK Holdings' net GAAP carrying value of the loan, and the company expects to recognize approximately $2.8 million in incremental income as a result of the transaction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SWK Holdings Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-043460), on October 01, 2025, and is solely responsible for the information contained therein.